Board approved additional investment of up to USD 15 million by subsidiary IKS Inc into associate company IKS WWMG MSO LLC.
Investment will increase IKS Inc's stake in WWMG MSO from 48.02% to 63.49% through subscription of common units.
Strategic rationale aims to transform from service provider to transformation partner in US healthcare services sector.
First tranche of USD 3 million to be invested by July 3, 2026, with full completion expected by March 31, 2029.
Inventurus Approves USD 15M IKS WWMG Investment
M&A / Stake Purchase / Joint Venture
Price while announcement
Current price (CMP)